Proteomic discovery of genistein action in the rat mammary gland.
Genistein, the primary isoflavone component of soy, consumed in diet during the prepubertal period suppresses chemically induced mammary cancer in rats. The current study used two-dimensional gel electrophoresis (2-DE)/MS-based proteomic technology to identify proteins responsible for genistein breast cancer protection In Vivo. Female offspring were exposed via lactating dams treated with 250 mg genistein/kg AIN-76A diet from days 1 to 21 postpartum (prepubertal period). Mammary glands were collected at 21 and 50 day of age and subjected to 2-DE/MS and immuno-blot analyses. Twenty-three proteins were determined to be differentially regulated (p < 0.05) and identified using 2-DE, followed by MALDI-TOF/TOF or LC-ESI-MS/MS. Five of these proteins were validated by immuno-blots. Annexin A2 was significantly increased at 21 days yet found to be decreased at 50 days. Fetuin B was found to be unchanged at day 21 but increased at day 50. Phosphoglycerate kinase 1 (PGK1) was unchanged at day 21 but decreased at day 50. Gelsolin was increased at day 21 but not at day 50. Protein disulfide-isomerase A3 (PDIA3) was decreased at day 21 and unchanged at day 50. Also, we found that vascular endothelial growth factor receptor 2 (VEGF-R2) and epidermal growth factor receptor (EGF-R) were decreased in mammary glands of 50-day-old rats treated prepubertally with genistein. This study demonstrates the usefulness of proteomics for the discovery of key proteins involved in signaling pathways to understand genistein mechanisms of action in breast cancer prevention.
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States. jun.wang@ccc.uab.edu
Jun
J
Wang
Angela M
AM
Betancourt
James A
JA
Mobley
Coral A
CA
Lamartiniere
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods; D005260:Female; D019833:Genistein / Q000494:pharmacology*; D008321:Mammary Glands, Animal / Q000737:chemistry* / Q000166:cytology / Q000187:drug effects*; D013058:Mass Spectrometry / Q000379:methods; D011506:Proteins / Q000032:analysis*; D020543:Proteome / Q000032:analysis / Q000187:drug effects; D040901:Proteomics / Q000379:methods*; D051381:Rats
D016588:Anticarcinogenic Agents; D011506:Proteins; D020543:Proteome; D019833:Genistein
Proc Soc Exp Biol Med. 1998 Mar;217(3):358-64
9492348
J Proteome Res. 2009 Nov;8(11):5041-7
19764771
Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1427-33
11557667
J Natl Cancer Inst. 1978 Dec;61(6):1439-49
102856
Hum Pathol. 2007 Mar;38(3):508-13
17239928
Cell Mol Life Sci. 2004 Oct;61(19-20):2614-23
15526166
Nature. 2000 Dec 14;408(6814):869-73
11130727
Mol Endocrinol. 1993 Nov;7(11):1445-55
7906861
J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):67-76
12160087
Carcinogenesis. 1998 Dec;19(12):2151-8
9886571
Toxicol Sci. 2000 Jun;55(2):311-9
10828262
Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):353-64
8061586
Am J Pathol. 1979 Sep;96(3):721-36
112872
Curr Pharm Des. 2007;13(35):3568-75
18220793
Clin Cancer Res. 2001 Aug;7(8):2415-24
11489821
Mol Cell Proteomics. 2005 Nov;4(11):1686-96
16048908
J Nutr. 2005 Dec;135(12 Suppl):2953S-2959S
16317154
Cell. 1981 Jun;24(3):741-52
6166387
Bull World Health Organ. 1970;43(2):209-21
5312521
Int J Cancer. 2006 Apr 1;118(7):1680-91
16217750
Mol Vis. 2009 Jun 17;15:1231-42
19536308
Cancer Res. 2002 Sep 15;62(18):5344-50
12235005
Biochem J. 2000 Sep 1;350 Pt 2:589-97
10947975
BMC Cancer. 2006 Aug 01;6:203
16882345
Bioessays. 1992 Nov;14(11):749-55
1285422
Cancer Res. 2003 Sep 15;63(18):6016-25
14522930
J Biol Chem. 1981 Nov 25;256(22):11381-4
6271744
Exp Mol Pathol. 2006 Oct;81(2):146-56
16643892
Genome. 2004 Oct;47(5):931-46
15499407
Cancer Res. 1996 Nov 1;56(21):4841-5
8895730
Anticancer Res. 2002 Jul-Aug;22(4):1933-41
12174867
Prostate. 1999 Jun 15;40(1):14-9
10344719
Carcinogenesis. 1995 Nov;16(11):2833-40
7586206
Biochim Biophys Acta. 1998 Apr 1;1397(1):102-17
9545551